For a variety of reasons, many Americans are uncertain about receiving the COVID-19 vaccines. One element is not knowing where to turn for trustworthy information.
Forty-three faculty members with a variety of clinical and research experience — representing 12 medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.
Front-line health care workers, including Jacobs School of Medicine and Biomedical Sciences faculty and medical residents, have begun receiving their COVID-19 vaccines, with some already receiving their second dose.
The first meeting of University at Buffalo’s Cancer Research Consortium was conducted virtually Dec. 10, where it was reported that faculty are working on 97 active cancer research awards totaling $7.4 million in annual direct funding.
A study of 24-to-28-month-old mice, the equivalent of 65-to-80-year-old adults, has found that frailty can be slowed with what might be considered “over” supplementation with vitamin D, referred to as “hypersufficiency.”
Western New Yorkers who were recently exposed to a household member who has tested positive for COVID-19 now have an opportunity to be treated with a promising drug being investigated for COVID-19 infection.
A team of internationally recognized scientists at the Jacobs School of Medicine and Biomedical Sciences are testing melatonin as a treatment for patients with mild and moderate COVID-19.
Nine faculty members and a staff member from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 17th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.
Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, was justifiably proud when the announcement of the Nobel Prize in Medicine or Physiology was made in early October.
